Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis

被引:7
|
作者
McLinden, Taylor [1 ]
Moodie, Erica E. M. [1 ]
Hamelin, Anne-Marie [1 ]
Harper, Sam [1 ]
Rossi, Carmine [1 ]
Walmsley, Sharon L. [2 ,3 ]
Rourke, Sean B. [4 ,5 ,6 ]
Cooper, Curtis [7 ]
Klein, Marina B. [8 ,9 ]
Cox, Joseph [1 ,8 ,9 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada
[4] Ontario HIV Treatment Network, Toronto, ON, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[8] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada
[9] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
Methadone treatment; Severe food insecurity; HIV; Hepatitis C virus; Propensity score matching; INFECTED INDIVIDUALS; C VIRUS; PREVALENCE; PEOPLE;
D O I
10.1016/j.drugalcdep.2017.12.031
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Severe food insecurity (FI) is common among individuals living with HIV-hepatitis C virus (HCV) co-infection. We hypothesize that the injection of opioids is partly responsible for the association between injection drug use and severe FI. Therefore, this analysis examines whether methadone maintenance treatment for opioid dependence is associated with a lower risk of severe Fl. Methods: We used biannual data from the Canadian Co-infection Cohort (N = 608, 2012-2015). Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module. To quantify the association between methadone treatment and severe FI, we estimated an average treatment effect on the treated (marginal risk difference [RD]) using propensity score matching. Results: Among participants, 25% experienced severe FI in the six months preceding the first time-point in the analytical sample and 5% concurrently reported receiving methadone treatment. Injection of opioids in the six months preceding the treatment and outcome measurements was much higher among those who received methadone treatment (39% vs. 12%). Among the treated participants, 97% had injected opioids in their lifetimes. After propensity score matching, the average risk of experiencing severe FI is 12.3 percentage-points lower among those receiving methadone treatment, compared to those who are not receiving treatment (marginal RD = -0.123, 95% CI = -0.230, 0.015). Conclusions: After adjustment for socioeconomic, sociodemographic, behavioural, and clinical confounders, methadone treatment is associated with a lower risk of severe FI. This finding suggests that methadone treatment may mitigate severe FI in this vulnerable subset of the HIV-positive population.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 50 条
  • [41] Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection
    Grebely, Jason
    Hellard, Margaret
    Applegate, Tanya
    Petoumenos, Kathy
    Yeung, Barbara
    Feld, Jordan J.
    Rawlinson, William
    Lloyd, Andrew R.
    George, Jacob
    Kaldor, John M.
    Dore, Gregory J.
    Matthews, Gail V.
    AIDS, 2012, 26 (13) : 1653 - 1661
  • [42] Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection
    Gupta, P.
    Liu, B.
    Wu, J. Q.
    Soriano, V.
    Vispo, E.
    Carroll, A. P.
    Goldie, B. J.
    Cairns, M. J.
    Saksena, N. K.
    VIROLOGY, 2014, 450 : 336 - 349
  • [43] Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance Network
    Otani, Machiko
    Shiino, Teiichiro
    Hachiya, Atsuko
    Gatanaga, Hiroyuki
    Watanabe, Dai
    Minami, Rumi
    Nishizawa, Masako
    Teshima, Takanori
    Yoshida, Shigeru
    Ito, Toshihiro
    Hayashida, Tsunefusa
    Koga, Michiko
    Nagashima, Mami
    Sadamasu, Kenji
    Kondo, Makiko
    Kato, Shingo
    Uno, Shunsuke
    Taniguchi, Toshibumi
    Igari, Hidetoshi
    Samukawa, Sei
    Nakajima, Hideaki
    Yoshino, Yusuke
    Horiba, Masahide
    Moro, Hiroshi
    Watanabe, Tamayo
    Imahashi, Mayumi
    Yokomaku, Yoshiyuki
    Mori, Haruyo
    Fujii, Teruhisa
    Takada, Kiyonori
    Nakamura, Asako
    Nakamura, Hideta
    Tateyama, Masao
    Matsushita, Shuzo
    Yoshimura, Kazuhisa
    Sugiura, Wataru
    Matano, Tetsuro
    Kikuchi, Tadashi
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26 (05)
  • [44] Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry
    Emma Gray
    David J. Pasta
    Suzanne Norris
    Aisling O’Leary
    BMC Health Services Research, 17
  • [45] Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis
    Pappalardo, BL
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2003, 32 (05) : 727 - 734
  • [46] SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis
    Dadashi, Masoud
    Dadashi, Ali
    Sameni, Fatemeh
    Sayadi, Shahram
    Goudarzi, Mehdi
    Nasiri, Mohammad Javad
    Yaslianifard, Somayeh
    Ghazi, Mona
    Arjmand, Reza
    Hajikhani, Bahareh
    GENE REPORTS, 2022, 27
  • [47] Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry
    Gray, Emma
    Pasta, David J.
    Norris, Suzanne
    O'Leary, Aisling
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [48] Utilization and Effectiveness of Home Treatment for People With Acute Severe Mental Illness: A Propensity-Score Matching Analysis of 19 Months of Observation
    Motteli, Sonja
    Schori, Dominik
    Schmidt, Helen
    Seifritz, Erich
    Jager, Matthias
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [49] Rates and predictors of response to anti-viral treatment for hepatitis C virus in HIV/HCV co-infection in a nationwide study of 619 patients
    Ioannou, G. N.
    Scott, J. D.
    Yang, Y.
    Green, P. K.
    Beste, L. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (11-12) : 1373 - 1384
  • [50] Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection:: Reversion by antiviral treatment with pegylated IFNα and ribavirin
    Gonzalez, Veronica D.
    Falconer, Karolin
    Michaelsson, Jakob
    Moll, Markus
    Reichard, Olle
    Alaeus, Annette
    Sandberg, Johan K.
    CLINICAL IMMUNOLOGY, 2008, 128 (01) : 46 - 56